SCHEMBL5287532

SCHEMBL5287532

COc1ccc(-c2csc(=NN=C(C)C)n2C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
HTT P42858 5/20 0.49
LMNA P02545 5/20 0.49
MAPK1 P28482 4/20 0.49
TDP1 Q9NUW8 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.45
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
PTGS2 P35354 1/20 0.38
STAT3 P40763 1/20 0.37
ALDH1A1 P00352 2/20 0.37
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5287377 0.85 SMN1; SMN2 (0.49) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5287384 0.85 SMN1; SMN2 (0.49) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5284067 0.84 MAPT (0.42) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5278421 0.83 MAPT (0.39) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5278424 0.83 MAPT (0.39) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5280481 0.83 SMN1; SMN2 (0.40) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5283764 0.82 SMN1; SMN2 (0.43) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5283771 0.82 SMN1; SMN2 (0.43) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL5281877 0.81 KMT2A (0.65) MAPTSMN1; SMN2HTTLMNAMAPK1
SCHEMBL4615109 0.80 MAPT (0.51) MAPTSMN1; SMN2HTTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP claimed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAPT 1807/4885SMN1; SMN2 3523/4885HTT 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.